Are FDA And CMS Growing Apart? AEI’s Gottlieb Thinks So
While many pharmaceutical industry observers like to talk about the new ways in which FDA and CMS are working together and sharing information, Scott Gottlieb is offering a contrarian view on relations between the two agencies
You may also be interested in...
HHS Secretary-nominee Tom Daschle tells Senate HELP Committee there needs to be better coordination within the department.
One of the first skirmishes in the 2009 health care reform debate is likely to occur over comparative effectiveness
Two major drug companies with significant hypertension profiles are welcoming the proposed inclusion of class-wide cardiovascular outcomes data in antihypertensive drug labeling - in contrast to other firms that commented on the FDA draft guidance